Aligos Therapeutics, Inc.
ALGS$20M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSOUTH SAN FRANCISCO70 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2027
45wMarket Overview
Stock performance and key metrics
ALGS News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ALG-000184 | Phase 2 | Chronic Hepatitis B Infection | - | - |
ALG-055009 | Phase 2 | NASH | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply